Equities

DermTech Inc

DMTKQ:PKL

DermTech Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.027
  • Today's Change-0.002 / -6.90%
  • Shares traded24.98k
  • 1 Year change-98.40%
  • Beta2.2759
Data delayed at least 15 minutes, as of Sep 20 2024 20:43 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year DermTech Inc grew revenues 5.36% from 14.52m to 15.30m while net income improved from a loss of 116.68m to a smaller loss of 100.89m.
Gross margin8.51%
Net profit margin-572.19%
Operating margin-588.62%
Return on assets-64.00%
Return on equity-121.75%
Return on investment-71.29%
More ▼

Cash flow in USDView more

In 2023, cash reserves at DermTech Inc fell by 41.04m. However, Cash Flow from Investing totalled 29.86m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 76.98m for operations while cash generated from financing totalled 6.08m.
Cash flow per share-2.61
Price/Cash flow per share--
Book value per share1.14
Tangible book value per share1.14
More ▼

Balance sheet in USDView more

DermTech Inc uses little debt in its capital structure as supported by a debt to capital ratio of 0.13%.
Current ratio3.53
Quick ratio3.46
Total debt/total equity0.0013
Total debt/total capital0.0013
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.